Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 26471
Gene Symbol: NUPR1
NUPR1
0.020 Biomarker disease BEFREE <b>Conclusions</b>: We propose that the T<sub>3</sub>/TR/NUPR1/PDGFA/MEK/ERK axis has a vital role in hepatocarcinogenesis and suggest NUPR1 as a potential therapeutic target in HCC. 31149049 2019
Entrez Id: 359806
Gene Symbol: PCNAP1
PCNAP1
0.010 Biomarker disease BEFREE <b>Methods</b>: We investigated the roles of lncRNA PCNAP1 in contribution of HBV replication through modulating miR-154/PCNA/HBV cccDNA signaling in hepatocarcinogenesis by using CRISPR/Cas9, Southern blot analysis, confocal assays, <i>et al.</i> in primary human hepatocytes (PHH), HepaRG cells, HepG2-NTCP cells, hepatoma carcinoma cells, human liver-chimeric mice model, transgenetic mice model, <i>in vitro</i> tumorigenicity and clinical patients. 31410212 2019
Entrez Id: 5111
Gene Symbol: PCNA
PCNA
0.030 Biomarker disease BEFREE <b>Methods</b>: We investigated the roles of lncRNA PCNAP1 in contribution of HBV replication through modulating miR-154/PCNA/HBV cccDNA signaling in hepatocarcinogenesis by using CRISPR/Cas9, Southern blot analysis, confocal assays, <i>et al.</i> in primary human hepatocytes (PHH), HepaRG cells, HepG2-NTCP cells, hepatoma carcinoma cells, human liver-chimeric mice model, transgenetic mice model, <i>in vitro</i> tumorigenicity and clinical patients. 31410212 2019
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.100 Biomarker disease BEFREE <b>Results:</b> GSEA revealed that several pathways and biological processes are associated with hepatocarcinogenesis, such as the cell cycle, DNA repair, and p53 pathway.A total of 160 DEGs were identified. 31737106 2019
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.100 PosttranslationalModification disease BEFREE 5'CpG islands methylation of p16 and p15 genes might be an early event in hepatocarcinogenesis. 15112341 2004
Entrez Id: 115482713
Gene Symbol: H3P10
H3P10
0.100 PosttranslationalModification disease BEFREE 5'CpG islands methylation of p16 and p15 genes might be an early event in hepatocarcinogenesis. 15112341 2004
Entrez Id: 1030
Gene Symbol: CDKN2B
CDKN2B
0.040 PosttranslationalModification disease BEFREE 5'CpG islands methylation of p16 and p15 genes might be an early event in hepatocarcinogenesis. 15112341 2004
Entrez Id: 10923
Gene Symbol: SUB1
SUB1
0.040 PosttranslationalModification disease BEFREE 5'CpG islands methylation of p16 and p15 genes might be an early event in hepatocarcinogenesis. 15112341 2004
Entrez Id: 29107
Gene Symbol: NXT1
NXT1
0.020 PosttranslationalModification disease BEFREE 5'CpG islands methylation of p16 and p15 genes might be an early event in hepatocarcinogenesis. 15112341 2004
Entrez Id: 115482684
Gene Symbol: H3P9
H3P9
0.020 PosttranslationalModification disease BEFREE 5'CpG islands methylation of p16 and p15 genes might be an early event in hepatocarcinogenesis. 15112341 2004
Entrez Id: 10573
Gene Symbol: MRPL28
MRPL28
0.020 PosttranslationalModification disease BEFREE 5'CpG islands methylation of p16 and p15 genes might be an early event in hepatocarcinogenesis. 15112341 2004
Entrez Id: 7099
Gene Symbol: TLR4
TLR4
0.020 Biomarker disease BEFREE Hepatocarcinogenesis in chronically injured livers depended on the intestinal microbiota and TLR4 activation in non-bone-marrow-derived resident liver cells. 22516259 2012
Entrez Id: 5244
Gene Symbol: ABCB4
ABCB4
0.040 Biomarker disease BEFREE Hepatocarcinogenesis in multidrug-resistant P-glycoprotein 3 deficiency. 28127842 2017
Entrez Id: 1351
Gene Symbol: COX8A
COX8A
0.010 Biomarker disease BEFREE Hepatocarcinogenesis was initiated by a single dose of intraperitoneal injection of diethylnitrosamine (DENA) (200 mg/kg BW) and promoted by phenobarbitone (500 ppm) in drinking water in groups V, VI, VII and VIII. 28372475 2017
Entrez Id: 213
Gene Symbol: ALB
ALB
0.050 Biomarker disease BEFREE Hepatocarcinogenesis Is Associated with Serum Albumin Levels after Sustained Virological Responses with Interferon-Based Therapy in Patients with Hepatitis C. 29040987 2017
Entrez Id: 6280
Gene Symbol: S100A9
S100A9
0.040 AlteredExpression disease BEFREE Calgranulin B was upregulated in colorectal cancer, and hepatoma-derived aldose reductase-like protein was reexpressed in a rat model during hepatocarcinogenesis. 10451122 1999
Entrez Id: 1544
Gene Symbol: CYP1A2
CYP1A2
0.020 Biomarker disease BEFREE CYP1A2 is not the primary enzyme responsible for 4-aminobiphenyl-induced hepatocarcinogenesis in mice. 10469630 1999
Entrez Id: 1499
Gene Symbol: CTNNB1
CTNNB1
0.100 GeneticVariation disease BEFREE beta-catenin mutation and deregulation may play an important role in hepatocarcinogenesis. 11443619 2001
Entrez Id: 5743
Gene Symbol: PTGS2
PTGS2
0.070 Biomarker disease BEFREE Cyclooxygenase 2 (COX-2) has been suggested to be associated with liver carcinogenesis. 12115513 2002
Entrez Id: 1012
Gene Symbol: CDH13
CDH13
0.010 Biomarker disease BEFREE CDH13, which functions in cell-cell adhesion, seems to be involved in liver carcinogenesis. 12374686 2002
Entrez Id: 10
Gene Symbol: NAT2
NAT2
0.020 AlteredExpression disease BEFREE NAT2 activity may be particulary critical in smoking related hepatocarcinogenesis. 12877350 2003
Entrez Id: 10395
Gene Symbol: DLC1
DLC1
0.070 Biomarker disease BEFREE DLC1, a tumour suppressor gene inactivated in liver carcinogenesis and encoding a Rho GTPase activating protein (RhoGAP) maps to one of the deleted regions (8p21.3-22). 15159023 2004
Entrez Id: 5743
Gene Symbol: PTGS2
PTGS2
0.070 Biomarker disease BEFREE COX-2 might represent an important cellular effector of HBx that contributes to hepatitis B virus-associated hepatocarcinogenesis. 15218507 2004
Entrez Id: 4513
Gene Symbol: COX2
COX2
0.010 Biomarker disease BEFREE COX-2 might represent an important cellular effector of HBx that contributes to hepatitis B virus-associated hepatocarcinogenesis. 15218507 2004
Entrez Id: 107075310
Gene Symbol: MTCO2P12
MTCO2P12
0.010 Biomarker disease BEFREE COX-2 might represent an important cellular effector of HBx that contributes to hepatitis B virus-associated hepatocarcinogenesis. 15218507 2004